BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23840852)

  • 1. Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice.
    Hsu TC; Tsai CC; Chiu CC; Hsu JD; Tzang BS
    PLoS One; 2013; 8(6):e68393. PubMed ID: 23840852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.
    Tsai CC; Chiu CC; Hsu JD; Hsu HS; Tzang BS; Hsu TC
    PLoS One; 2013; 8(3):e59724. PubMed ID: 23555760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lin TM; Tsai CC; Hsu JD; Yang LC; Hsu TC
    Mol Immunol; 2011 Jul; 48(12-13):1518-24. PubMed ID: 21555155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Root Extract of Gentiana macrophylla Pall. Alleviates B19-NS1-Exacerbated Liver Injuries in NZB/W F1 Mice.
    Sheu MJ; Chiu CC; Yang DJ; Hsu TC; Tzang BS
    J Med Food; 2017 Jan; 20(1):56-64. PubMed ID: 28060552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein.
    Tsai CC; Tzang BS; Chiang SY; Hsu GJ; Hsu TC
    J Biomed Sci; 2009 Jan; 16(1):14. PubMed ID: 19272186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
    Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
    Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin Increases Antioxidant Activities and Ameliorates Hepatic Fibrosis in Lupus-Prone Mice Fed with a High-Cholesterol Diet.
    Chen HA; Chiu CC; Huang CY; Chen LJ; Tsai CC; Hsu TC; Tzang BS
    J Med Food; 2016 Jul; 19(7):670-7. PubMed ID: 27332506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice.
    Tzang BS; Chiang SY; Lai WX; Tsai CC; Wu JH; Hsu TC
    Int Immunopharmacol; 2008 Apr; 8(4):589-96. PubMed ID: 18328451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.
    Chen BL; Peng J; Li QF; Yang M; Wang Y; Chen W
    World J Gastroenterol; 2013 Mar; 19(9):1405-15. PubMed ID: 23539268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection.
    Chen DY; Chen YM; Tzang BS; Lan JL; Hsu TC
    PLoS One; 2014; 9(12):e113889. PubMed ID: 25462010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
    Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
    Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
    Chen DY; Tzang CC; Liu CM; Chiu TM; Lin JW; Chuang PH; Kuo CW; Tzang BS; Hsu TC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.
    Hsu TC; Tzang BS; Huang CN; Lee YJ; Liu GY; Chen MC; Tsay GJ
    Clin Exp Immunol; 2006 Apr; 144(1):152-7. PubMed ID: 16542377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.
    Tzang BS; Chen DY; Tsai CC; Chiang SY; Lin TM; Hsu TC
    J Biomed Sci; 2010 May; 17(1):40. PubMed ID: 20500824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice.
    Nakamura T; Ebihara I; Fukui M; Osada S; Tomino Y; Masaki T; Goto K; Furuichi Y; Koide H
    Ren Physiol Biochem; 1993; 16(5):233-43. PubMed ID: 7694336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
    Lu J; Zhang J; Wang Y; Sun Q
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.